Overview

TTA in Treatment of Diabetes and Dyslipidemia

Status:
Completed

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

Summary

The aim of the study is to evaluate the short-term effects of tetradecylthioacetic acid (TTA) on plasma lipids and glucose in male patients with type 2 diabetes mellitus and dyslipidemia

Phase:

Phase 2

Details

Lead Sponsor:

Haukeland University Hospital

Collaborator:

University of Bergen

Treatments:

1-(carboxymethylthio)tetradecane